Sio Capital Management’s Neurogene NGNE Stock Holding History

Sio Capital Management’s Portfolio NGNE Stock Details NGNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,916	Closed	-$19.5K	–	49
2022 Q4	$19.5K	Hold	1,916	–	–	0.01%	46
2022 Q3	$25K	Hold	1,916	–	–	0.01%	48
2022 Q2	$39K	Hold	1,916	–	–	0.01%	60
2022 Q1	$72K	Hold	1,916	–	–	0.02%	65
2021 Q4	$185K	Hold	1,916	–	–	0.06%	66
2021 Q3	$277K	Hold	1,916	–	–	0.09%	57
2021 Q2	$354K	Hold	1,916	–	–	0.09%	72
2021 Q1	$472K	Hold	1,916	–	–	0.1%	84
2020 Q4	$540K	Hold	1,916	–	–	0.11%	86
2020 Q3	$460K	Hold	1,916	–	–	0.09%	81
2020 Q2	$636K	Sell	1,916 -2,493	-57%	-$650K	0.19%	70
2020 Q1	$1M	Hold	4,409	–	–	0.34%	49
2019 Q4	$1.09M	Buy	+4,409	New	+$439K	0.26%	59

Other funds holding NGNE

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sio Capital Management's NGNE Position: Q1 2023 in Review

Sio Capital Management sold out of Neurogene (NGNE) in Q1 2023, closing a stake of 1,916 shares — an estimated $19.5K sold.

Sio Capital Management first reported a position in NGNE in Q4 2019 and held it in 13 quarters. The position peaked at $1.09M in Q4 2019. 39 funds tracked by Wall St. Rank hold NGNE as of Q1 2023.

Sio Capital Management reported no remaining Neurogene position as of Q1 2023 after selling out during the quarter.
Sio Capital Management sold 1,916 Neurogene shares in Q1 2023, an estimated $19.5K.
Sio Capital Management first reported a position in Neurogene in Q4 2019 and held it in 13 quarters.
Sio Capital Management's Neurogene position peaked at $1.09M in Q4 2019.
39 funds tracked by Wall St. Rank held Neurogene as of Q1 2023.

Based on Sio Capital Management's 13F filing for Q1 2023, filed 12 May 2023.